retatrutide fat loss trial New Phase 3 data just dropped 👀 Eli Lilly's reported average weight approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide Side Effects: What Patients

Key takeaways Chinas GLP-1 market is booming, driven by rising diabetes and obesity prevalence, expanded indications (e.g., MASH, CKD, Alzheimers), policy support and momentum from global leaders and innovative local players

Its biggest weakness is medical oversight, lab requirements vary, compounded drugs raise quality concerns, and limited coaching reduces long-term success

But he was not very happy about me going on a GLP-1

Mechanism 1: Adipose tissue estrogen release during rapid fat loss

Our structure appears to capture a catalytically competent state where the GSH thiol is in proximity to an arginine, located in TM4, essential for catalysis